This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Singapore, Spain, UK.
The drug LONSURF contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
RMW9V5RW38 - TRIFLURIDINE
|
2
|
UNII
4H59KLQ0A4 - TIPIRACIL HYDROCHLORIDE
|
|
Tipiracil helps maintain the blood concentration of trifluridine by inhibiting the enzyme thymidine phosphorylase which metabolizes trifluridine. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| L01BC59 | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01B Antimetabolites → L01BC Pyrimidine analogues | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| AU | Pharmaceutical Benefits Scheme | 11507P, 11524M, 12033H, 12056M |
| BR | Câmara de Regulação do Mercado de Medicamentos | 531320090011107, 531320090011207, 531320090011307, 531320090011407 |
| CA | Health Products and Food Branch | 02472104, 02472112 |
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 5189-MEE-0620, 5190-MEE-0620 |
| EE | Ravimiamet | 1716319, 1716320, 1716331, 1716342, 1716353, 1716364 |
| ES | Centro de información online de medicamentos de la AEMPS | 1161096001, 1161096003, 1161096004, 1161096006 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 057979, 158698, 389330, 516182 |
| FR | Base de données publique des médicaments | 65185956, 69681469 |
| GB | Medicines & Healthcare Products Regulatory Agency | 329756, 329757, 329761, 329762 |
| HK | Department of Health Drug Office | 65360, 65361 |
| IE | Health Products Regulatory Authority | 88850, 88851, 88852, 88853 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 8802, 8803 |
| IT | Agenzia del Farmaco | 044856019, 044856021, 044856033, 044856045, 044856058, 044856060 |
| JP | 医薬品医療機器総合機構 | 4299100F1026, 4299100F2022 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1080198, 1080199, 1080200, 1080201, 1080202, 1080203 |
| NL | Z-Index G-Standaard, PRK | 137510, 137529 |
| PL | Rejestru Produktów Leczniczych | 100370700, 100370716 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W63841001, W63841002, W63842001, W63842002 |
| SG | Health Sciences Authority | 15491P, 15494P |
| US | FDA, National Drug Code | 64842-1020, 64842-1025 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.